Activation of TGR5 Alleviates Renal Fibrosis by Promoting NEDD4L ‐Mediated p‐Smad2/3 Ubiquitination
Acta Physiologica · 2026
DOI: 10.1111/apha.70163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Physiologica, 2026. Verfasst von Meng Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hypertension, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Smad3 Protein, Smad2 Protein, Nedd4 Ubiquitin Protein Ligases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Aim
Renal fibrosis is a major contributor to chronic kidney disease (CKD) progression and eventual organ failure. G protein‐coupled bile acid receptor 1 (TGR5) was previously shown to have beneficial effects on kidney diseases. The current study aimed to investigate whether TGR5 activation prevents kidney fibrosis and to clarify the underlying mechanism.
Methods
TGR5 expression was examined in human fibrotic kidneys. Two animal models of renal fibrosis were used: unilateral ureteral obstruction (UUO) and unilateral ischemia–reperfusion injury with contralateral nephrectomy (uIRIx) in wild‐type and TGR5 knockout mice. Renal histology, extracellular matrix (ECM) deposition, and renal function were examined. In vitro studies were performed on human proximal tubular HK2 cells by treating them with transforming growth factor‐β1 and TGR5 agonists/antagonists.
Results
TGR5 was significantly downregulated in fibrotic human kidneys. In both UUO and uIRIx models, TGR5 activation by lithocholic acid alleviated renal fibrosis, reduced ECM deposition, and improved kidney function. Conversely, Tgr5 knockout in mice exacerbated fibrotic injury. Mechanistically, TGR5 activation prevented fibrosis development, probably by enhancing NEDD4L‐mediated ubiquitination and degradation of phosphorylated Smad2/3 by inhibiting the upstream PI3K–SGK1 pathway.
Conclusion
TGR5 activation protects against renal fibrosis by inhibiting the PI3K–SGK1–NEDD4L axis and promoting p‐Smad2/3 degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Hypertension, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
- Department of Physiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
- Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
- Department of Pathology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
- School of Pharmacy, University College London, London, UK.
- Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Xi Yuan, Xinyan Wu, Suchun Li, Chunling Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Li, M., Long, L., Zhao, X., Yuan, X., Wang, M., Lin, J., Xu, L., Wu, X., Bai, R., Li, S., Wang, W., Chen, W., Lu, L., & Li, C. (2026). Activation of TGR5 Alleviates Renal Fibrosis by Promoting NEDD4L ‐Mediated p‐Smad2/3 Ubiquitination. Acta Physiologica. https://doi.org/10.1111/apha.70163
Vancouver
Li M, Long L, Zhao X, Yuan X, Wang M, Lin J, et al. Activation of TGR5 Alleviates Renal Fibrosis by Promoting NEDD4L ‐Mediated p‐Smad2/3 Ubiquitination. Acta Physiologica. 2026. doi:10.1111/apha.70163
BibTeX
@article{Li2026,
author = {Li, Meng and Long, Luosha and Zhao, Xiaoduo and Yuan, Xi and Wang, Minghui and Lin, Jinyi and Xu, Long and Wu, Xinyan and Bai, Ruiqi and Li, Suchun and Wang, Weidong and Chen, Wei and Lu, Lihe and Li, Chunling},
title = {Activation of TGR5 Alleviates Renal Fibrosis by Promoting NEDD4L ‐Mediated p‐Smad2/3 Ubiquitination},
journal = {Acta Physiologica},
year = {2026},
doi = {10.1111/apha.70163}
}
EUVIMED